Central nervous side effects following ifosfamide monotherapy of advanced renal carcinoma
- PMID: 7240342
- PMCID: PMC12253027
- DOI: 10.1007/BF00405909
Central nervous side effects following ifosfamide monotherapy of advanced renal carcinoma
Abstract
Ten patients with advanced renal carcinoma were treated by ifosfamide (50-60 mg/kd/day x 5 days). The treatment was repeated every 4 weeks and continued until progression appeared. Two patients came into partial remission, two had subjective improvement, and six did not respond. Seven patients developed acute psychopathological symptoms during the first ifosfamide-cycle. Five patients had visual and paranoid hallucinations, four patients were completely confused. Follow-up for up to 10 weeks showed a persisting organic brain syndrome in five patients.
References
-
- Allen LM, Creaven PJ (1975) Pharmacokinetics of ifosfamide. Clin Pharmacol Ther 17:492–498 - PubMed
-
- Creaven PJ, Allen LM, Alford DA, Cohen MH (1974) Clinical pharmacology of isophosphamide. Clin Pharmacol Ther 16:77–86 - PubMed
-
- Hartwich G, Neidhardt B, Lutz H (1978) Klinische Erfahrungen mit Holoxan im Rahmen einer sequentiellen Kombinationstherapie. Med Klin 73:1247–1252 - PubMed
-
- Hoefer-Janker H, Scheef W, Günther U, Hüls W (1975) Erfahrungen mit der fraktionierten Ifosfamid-Stoßtherapie bei generalisierten malignen tumoren. Med Welt 26:972–979 - PubMed
-
- Ritter S, Schröder HJ (1977) Klinische Erfahrungen mit dem Zytostatikum Ifosfamid. Med Welt 28:1395–1400 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical